(Q46990986)

27 December 2017

title

Osteoporosis: non-hormonal treatment (English)

1 reference

27 December 2017

0 references

R Rizzoli

1

1 reference

27 December 2017

publication date

1 October 2007

1 reference

27 December 2017

published in

Climacteric

1 reference

27 December 2017

volume

10 Suppl 2

1 reference

27 December 2017

page(s)

74-78

1 reference

27 December 2017

Ten years' experience with alendronate for osteoporosis in postmenopausal women

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Efficacy of risedronate on clinical vertebral fractures within six months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Effect of Vitamin D on falls: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Denosumab in postmenopausal women with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

Intravenous ibandronate injections in postmenopausal women with osteoporosis: One-year results from the dosing intravenous administration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701600815

10.1080/13697130701600815

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017